1
TITLE: Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial
AUTHORS: Matthew A Powell; Virginia L Filiaci; Martee L Hensley; Helen Q Huang; Kathleen N Moore; Krishnansu S Tewari; Larry J Copeland; Angeles A Secord; David G Mutch; Alessandro Santin; David P Warshal; Nick M Spirtos; Paul A DiSilvestro; Olga B Ioffe; David Scott Miller ;
PUBLISHED: 2022, SOURCE: Journal of Clinical Oncology, VOLUME: 40, ISSUE: 9
INDEXED IN: Scopus CrossRef: 35
2
TITLE: Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study. Race and endometrial carcinoma recurrence  Full Text
AUTHORS: Felix A.S.; Brasky T.M.; Cohn D.E.; Mutch D.G.; Creasman W.T.; Thaker P.H.; Walker J.L.; Moore R.G.; Lele S.B.; Guntupalli S.R.; Downs L.S.; Ci Nagel; Boggess J.F.; Pearl M.L.; Ioffe O.B.; Deng W.; David Scott Miller ; Brinton L.A.;
PUBLISHED: 2018, SOURCE: International Journal of Cancer, VOLUME: 142, ISSUE: 6
INDEXED IN: Scopus CrossRef: 14